Literature DB >> 7496265

HTLV-I screening in Britain.

A Pagliuca, R Pawson, G J Mufti.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7496265      PMCID： PMC2551236          DOI： 10.1136/bmj.311.7016.1313

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  HTLV-I/II antibodies in French blood donors.

Authors:  J Coste; J M Lemaire; F Barin; A M Courouce
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

2.  HTLV-I/II antibodies in UK blood donors.

Authors:  R Salker; J H Tosswill; J A Barbara; J Runganga; M Contreras; R S Tedder; N Parra-Mejia; P P Mortimer
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

3.  Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.

Authors:  J E Banatvala; I L Chrystie; S J Palmer; A Kenney
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

4.  Blood transfusion and HTLV-I associated myelopathy.

Authors:  M Osame; S Izumo; A Igata; M Matsumoto; T Matsumoto; S Sonoda; M Tara; Y Shibata
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

5.  HTLV screening of Swedish blood donors.

Authors:  J Giesecke
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

6.  Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.

Authors:  H Vrielink; C L van der Poel; H W Reesink
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

7.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

8.  A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients.

Authors:  K Okochi; H Sato; Y Hinuma
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

9.  Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion.

Authors:  Y C Chen; C H Wang; I J Su; C Y Hu; M J Chou; T H Lee; D T Lin; T Y Chung; C H Liu; C S Yang
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

10.  Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.

Authors:  P Flanagan; L McAlpine; S J Ramskill; A G Smith; R Eglin; J V Parry; P P Mortimer
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144
View more
  6 in total

1.  Making British blood supply safer.

Authors:  P Flanagan
Journal:  BMJ       Date:  1996-06-29

2.  Prevalence of Human T Cell Leukaemia Virus amongst Blood Donors.

Authors:  C N Chaudhari; T Shah; R N Misra
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  HTLV-I screening in Britain. Blood supply in Britain should be made safer.

Authors:  L A Kay
Journal:  BMJ       Date:  1996-03-16

4.  HTLV-I screening in Britain. Failure to screen may be a false economy.

Authors:  P Harrison; F A Ala; D W Milligan; S Skidmore
Journal:  BMJ       Date:  1996-03-16

5.  HTLV-I screening in Britain. Antenatal screening is important.

Authors:  J N Weber; G P Taylor
Journal:  BMJ       Date:  1996-03-16

6.  Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Ngozi Immaculata Ugwu; Chukwudi Simon Anigbo; Charles Emeka Nonyelu
Journal:  J Blood Med       Date:  2015-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.